Patents by Inventor Quxiang LI

Quxiang LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,5-DIHYDRO-2,4-BENZODIAZEPINE-3-ONE DERIVATIVE AND APPLICATION THEREOF
    Publication number: 20230132621
    Abstract: 1,5-dihydro-2,4-benzodiazepine-3-one derivatives, such as a compound represented by formula I, acts on 5-HT2A and 5-HT2C receptors. The selectivity for 5-HT2A is superior or similar to pimavanserin. The derivative is used for treating schizophrenia or Parkinson’s disease, dementia-related behavioral disorders, and psychosis. The antipsychotic activity of the compound is equivalent to that of pimavanserin, the side effects of sedation and and worsening of exercise are less than those of pimavanserin, and cardiotoxicity is less than that of pimavanserin.
    Type: Application
    Filed: October 20, 2022
    Publication date: May 4, 2023
    Inventors: Xiangqing XU, Yinli QIU, Qiang GUO, Minquan YU, Song ZHAO, Quxiang LI, Peng JING, Yuanyuan HOU, Yingying DONG, Guosheng WU, Shuang ZHANG, Aijun LU